Lane D A, Olds R J, Conard J, Boisclair M, Bock S C, Hultin M, Abildgaard U, Ireland H, Thompson E, Sas G
Charing Cross and Westminster Medical School, London, United Kingdom.
J Clin Invest. 1992 Dec;90(6):2422-33. doi: 10.1172/JCI116133.
Six different substitution mutations were identified in four different amino acid residues of antithrombin strand 1C and the polypeptide leading into strand 4B (F402S, F402C, F402L, A404T, N405K, and P407T), and are responsible for functional antithrombin deficiency in seven independently ascertained kindreds (Rosny, Torino, Maisons-Laffitte, Paris 3, La Rochelle, Budapest 5, and Oslo) affected by venous thromboembolic disease. In all seven families, variant antithrombins with heparin-binding abnormalities were detected by crossed immunoelectrophoresis, and in six of the kindreds there was a reduced antigen concentration of plasma antithrombin. Two of the variant antithrombins, Rosny and Torino, were purified by heparin-Sepharose and immunoaffinity chromatography, and shown to have greatly reduced heparin cofactor and progressive inhibitor activities in vitro. The defective interactions of these mutants with thrombin may result from proximity of s1C to the reactive site, while reduced circulating levels may be related to s1C proximity to highly conserved internal beta strands, which contain elements proposed to influence serpin turnover and intracellular degradation. In contrast, s1C is spatially distant to the positively charged surface which forms the heparin binding site of antithrombin; altered heparin binding properties of s1C variants may therefore reflect conformational linkage between the reactive site and heparin binding regions of the molecule. This work demonstrates that point mutations in and immediately adjacent to strand 1C have multiple, or pleiotropic, effects on this serpin, leading ultimately to failure of its regulatory function.
在抗凝血酶1C链及通向4B链的多肽的四个不同氨基酸残基中鉴定出六种不同的替代突变(F402S、F402C、F402L、A404T、N405K和P407T),这些突变导致了七个独立确诊的患有静脉血栓栓塞性疾病的家族(罗斯尼、都灵、梅森拉菲特、巴黎3区、拉罗谢尔、布达佩斯5区和奥斯陆)出现功能性抗凝血酶缺乏。在所有七个家族中,通过交叉免疫电泳检测到具有肝素结合异常的变异抗凝血酶,并且在其中六个家族中血浆抗凝血酶的抗原浓度降低。其中两种变异抗凝血酶,即罗斯尼和都灵变异体,通过肝素-琼脂糖和免疫亲和层析进行了纯化,并显示在体外具有大大降低的肝素辅因子和进行性抑制剂活性。这些突变体与凝血酶之间有缺陷的相互作用可能是由于1C链靠近反应位点,而循环水平降低可能与1C链靠近高度保守的内部β链有关,这些内部β链包含被认为影响丝氨酸蛋白酶抑制剂周转和细胞内降解的元件。相比之下,1C链在空间上远离形成抗凝血酶肝素结合位点的带正电荷表面;因此,1C链变异体改变的肝素结合特性可能反映了该分子反应位点和肝素结合区域之间的构象联系。这项研究表明,1C链及其紧邻区域的点突变对这种丝氨酸蛋白酶抑制剂有多种或多效性影响,最终导致其调节功能失效。